세계의 방사선 치료 시장 보고서(2025년)

Radiotherapy is a medical treatment that utilizes high doses of radiation to destroy cancer cells and shrink tumors. It is commonly used to treat various types of cancer, either as a standalone therapy or in combination with surgery and chemotherapy.

The primary types of radiotherapy include external beam radiation therapy, internal beam radiation therapy, and systemic radiation therapy. External beam radiation therapy delivers high-energy radiation from an external machine to target and destroy cancer cells. This treatment is applied to various cancers, including prostate, breast, lung, head and neck, colorectal, gynecological, cervical, and penile cancers, among others. It is used by multiple end users, such as hospitals and diagnostic labs, cancer treatment and research centers, academic institutions, and ambulatory surgery centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The radiotherapy market research report is one of a series of new reports from The Business Research Company that provides radiotherapy market statistics, including the radiotherapy industry's global market size, regional shares, competitors with a radiotherapy market share, detailed radiotherapy market segments, market trends and opportunities, and any further data you may need to thrive in the radiotherapy industry. This radiotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The radiotherapy market size has grown strongly in recent years. It will grow from $7.38 billion in 2024 to $7.89 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to an increase in the incidence of cancer cases globally, growth in demand for non-invasive cancer treatments, expansion of healthcare infrastructure, rise in adoption of personalized medicine, and rise in patient population requiring cancer treatment.

The radiotherapy market size is expected to see strong growth in the next few years. It will grow to $10.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing investment in advanced healthcare technologies, increasing focus on minimally invasive treatment options, rising demand for home-based healthcare solutions, increasing focus on quality assurance programs, and increasing global health initiatives addressing cancer care. Major trends in the forecast period include advancements in image-guided radiotherapy, advancements in particle therapy, development of novel brachytherapy techniques, advancements in cyberKnife technology, and integration of artificial intelligence in treatment planning.

The forecast of 6.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of proton therapy gantry components sourced from France and Italy, thereby delaying advanced cancer treatments and elevating radiation oncology department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of cancer is anticipated to drive the expansion of the radiotherapy market. Cancer is a disease characterized by the uncontrolled growth of abnormal cells that can invade and spread to other parts of the body, affecting various tissues and organs and leading to a wide range of symptoms. The increasing incidence of cancer is linked to factors such as an aging population, lifestyle changes including poor diet and physical inactivity, high tobacco and alcohol consumption, environmental pollution, and advancements in diagnostic tools that enable earlier detection. Radiotherapy plays a vital role in cancer treatment by precisely targeting and destroying cancerous cells, reducing tumor size, and improving patient outcomes. For example, in August 2024, Macmillan Cancer Support, a UK-based charitable organization supporting cancer patients, reported that more than 3 million people in the UK were living with cancer, with projections indicating an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the rising prevalence of cancer is fueling the growth of the radiotherapy market.

Leading companies in the radiotherapy market are prioritizing the development of innovative technologies, such as image-guided radiotherapy (IGRT), to enhance treatment precision, improve patient outcomes, and minimize damage to surrounding healthy tissues. IGRT utilizes advanced imaging tools to ensure accurate tumor targeting during radiation therapy, allowing real-time tracking and adjustments to the tumor's position for increased precision. For instance, in May 2022, Elekta AB, a Sweden-based medical technology company, introduced the Elekta Esprit, a next-generation radiosurgery system that enhances the capabilities of stereotactic radiosurgery. This system integrates multiple innovations into a single platform, offering superior visualization and remote accessibility for treatment teams. It supports flexible workflow options, including single-session, fractionated, adaptive, or staged protocols, optimizing ease of use and efficiency in clinical settings. With an accuracy of less than 0.3 mm, the system is designed to treat even the most challenging targets while preserving surrounding healthy tissues.

In February 2024, Bristol Myers Squibb, a US-based pharmaceutical company, acquired RayzeBio Inc. for an undisclosed amount. This acquisition strengthens its oncology pipeline with advanced radiopharmaceutical therapeutics, including RYZ101, which targets SSTR2 in GEP-NETs and ES-SCLC. With ongoing clinical trials and a state-of-the-art manufacturing facility, this strategic move enables Bristol Myers Squibb to accelerate innovation, expand treatment options, and drive growth in the oncology sector. RayzeBio Inc. is a US-based company specializing in the development of innovative radiopharmaceuticals for cancer treatment.

Major players in the radiotherapy market are Hitachi Ltd., Koninklijke Philips N.V., GE Healthcare Technologies Inc., Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Ion Beam Applications S.A, Canon Medical Systems Corporation, RefleXion Medical Inc., Mevion Medical Systems Inc., Nordion Inc., Theragenics Corporation, RaySearch Laboratories AB, MIM Software Inc., Vision RT Ltd., Sun Nuclear Corporation, Provision Healthcare LLC, Panacea Medical Technologies Pvt. Ltd., Optivus Proton Therapy Inc., Perspective Therapeutics Inc., GT Medical Technologies Inc., ProTom International Inc.

North America was the largest region in the radiotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in radiotherapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the radiotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiotherapy market includes revenues earned by entities by providing services such as brachytherapy, palliative radiotherapy, proton therapy, and intraoperative radiotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The radiotherapy market consists of sales of patient positioning systems, surface-guided radiation therapy systems (SGRT), CT and MRI simulation systems, and linear accelerators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiotherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The radiotherapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapy Type: External Beam Radiation Therapy; Internal Beam Radiation Therapy; Systemic Radiation Therapy
• 2) By Application: Prostate Cancer; Breast Cancer; Lung Cancer; Head And Neck Cancer; Colorectal Cancer; Gynecological Cancer; Cervical Cancer; Penile Cancer; Other Applications
• 3) By End-User: Hospitals And Diagnostic Laboratories; Cancer Treatment And Research Centers; Academic Research Organizations; Ambulatory Surgery Centers; Other End-Users
• Subsegments:
• 1) By External Beam Radiation Therapy: Intensity-Modulated Radiation Therapy (IMRT); Stereotactic Body Radiation Therapy (SBRT); 3D Conformal Radiation Therapy (3D-CRT); Proton Beam Therapy; Image-Guided Radiation Therapy (IGRT); Volumetric Modulated Arc Therapy (VMAT)
• 2) By Internal Beam Radiation Therapy: Brachytherapy (High-Dose Rate); Brachytherapy (Low-Dose Rate); Intraoperative Radiation Therapy (IORT); Permanent Seed Implants
• 3) By Systemic Radiation Therapy: Radioisotope Therapy; Targeted Radionuclide Therapy; Radioimmunotherapy; Peptide Receptor Radionuclide Therapy (PRRT)
• Companies Mentioned: Hitachi Ltd.; Koninklijke Philips N.V.; GE Healthcare Technologies Inc.; Sumitomo Heavy Industries Ltd.; Varian Medical Systems Inc.; Elekta AB; Accuray Incorporated; Ion Beam Applications S.A; Canon Medical Systems Corporation; RefleXion Medical Inc.; Mevion Medical Systems Inc.; Nordion Inc.; Theragenics Corporation; RaySearch Laboratories AB; MIM Software Inc.; Vision RT Ltd.; Sun Nuclear Corporation; Provision Healthcare LLC; Panacea Medical Technologies Pvt. Ltd.; Optivus Proton Therapy Inc.; Perspective Therapeutics Inc.; GT Medical Technologies Inc.; ProTom International Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiotherapy Market Characteristics

3. Radiotherapy Market Trends And Strategies

4. Radiotherapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Radiotherapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Radiotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Radiotherapy Market Growth Rate Analysis
• 5.4. Global Radiotherapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Radiotherapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Radiotherapy Total Addressable Market (TAM)

6. Radiotherapy Market Segmentation

• 6.1. Global Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• External Beam Radiation Therapy
• Internal Beam Radiation Therapy
• Systemic Radiation Therapy
• 6.2. Global Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Head And Neck Cancer
• Colorectal Cancer
• Gynecological Cancer
• Cervical Cancer
• Penile Cancer
• Other Applications
• 6.3. Global Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Diagnostic Laboratories
• Cancer Treatment And Research Centers
• Academic Research Organizations
• Ambulatory Surgery Centers
• Other End-Users
• 6.4. Global Radiotherapy Market, Sub-Segmentation Of External Beam Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intensity-Modulated Radiation Therapy (IMRT)
• Stereotactic Body Radiation Therapy (SBRT)
• 3D Conformal Radiation Therapy (3D-CRT)
• Proton Beam Therapy
• Image-Guided Radiation Therapy (IGRT)
• Volumetric Modulated Arc Therapy (VMAT)
• 6.5. Global Radiotherapy Market, Sub-Segmentation Of Internal Beam Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Brachytherapy (High-Dose Rate)
• Brachytherapy (Low-Dose Rate)
• Intraoperative Radiation Therapy (IORT)
• Permanent Seed Implants
• 6.6. Global Radiotherapy Market, Sub-Segmentation Of Systemic Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radioisotope Therapy
• Targeted Radionuclide Therapy
• Radioimmunotherapy
• Peptide Receptor Radionuclide Therapy (PRRT)

7. Radiotherapy Market Regional And Country Analysis

• 7.1. Global Radiotherapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Radiotherapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Radiotherapy Market

• 8.1. Asia-Pacific Radiotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Radiotherapy Market

• 9.1. China Radiotherapy Market Overview
• 9.2. China Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Radiotherapy Market

• 10.1. India Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Radiotherapy Market

• 11.1. Japan Radiotherapy Market Overview
• 11.2. Japan Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Radiotherapy Market

• 12.1. Australia Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Radiotherapy Market

• 13.1. Indonesia Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Radiotherapy Market

• 14.1. South Korea Radiotherapy Market Overview
• 14.2. South Korea Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Radiotherapy Market

• 15.1. Western Europe Radiotherapy Market Overview
• 15.2. Western Europe Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Radiotherapy Market

• 16.1. UK Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Radiotherapy Market

• 17.1. Germany Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Radiotherapy Market

• 18.1. France Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Radiotherapy Market

• 19.1. Italy Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Radiotherapy Market

• 20.1. Spain Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Radiotherapy Market

• 21.1. Eastern Europe Radiotherapy Market Overview
• 21.2. Eastern Europe Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Radiotherapy Market

• 22.1. Russia Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Radiotherapy Market

• 23.1. North America Radiotherapy Market Overview
• 23.2. North America Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Radiotherapy Market

• 24.1. USA Radiotherapy Market Overview
• 24.2. USA Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Radiotherapy Market

• 25.1. Canada Radiotherapy Market Overview
• 25.2. Canada Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Radiotherapy Market

• 26.1. South America Radiotherapy Market Overview
• 26.2. South America Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Radiotherapy Market

• 27.1. Brazil Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Radiotherapy Market

• 28.1. Middle East Radiotherapy Market Overview
• 28.2. Middle East Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Radiotherapy Market

• 29.1. Africa Radiotherapy Market Overview
• 29.2. Africa Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Radiotherapy Market Competitive Landscape And Company Profiles

• 30.1. Radiotherapy Market Competitive Landscape
• 30.2. Radiotherapy Market Company Profiles
  • 30.2.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Radiotherapy Market Other Major And Innovative Companies

• 31.1. Elekta AB
• 31.2. Accuray Incorporated
• 31.3. Ion Beam Applications S.A
• 31.4. Canon Medical Systems Corporation
• 31.5. RefleXion Medical Inc.
• 31.6. Mevion Medical Systems Inc.
• 31.7. Nordion Inc.
• 31.8. Theragenics Corporation
• 31.9. RaySearch Laboratories AB
• 31.10. MIM Software Inc.
• 31.11. Vision RT Ltd.
• 31.12. Sun Nuclear Corporation
• 31.13. Provision Healthcare LLC
• 31.14. Panacea Medical Technologies Pvt. Ltd.
• 31.15. Optivus Proton Therapy Inc.

32. Global Radiotherapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiotherapy Market

34. Recent Developments In The Radiotherapy Market

35. Radiotherapy Market High Potential Countries, Segments and Strategies

• 35.1 Radiotherapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Radiotherapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Radiotherapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer